2. Inflammation/Immunology

Inflammation/Immunology

Inflammation/Immunology

Related Products

PDF 93.1 MB

The diseases caused by disorders of the immune system fall into two broad categories: immunodeficiency and autoimmunity. Immunotherapy is also often used in the immunosuppressed (such as HIV patients) and people suffering from other immune deficiencies or autoimmune diseases. This includes regulating factors such as IL-2, IL-10, IFN-α. Infection with HIV is characterized not only by development of profound immunodeficiency but also by sustained inflammation and immune activation. Chronic inflammation as a critical driver of immune dysfunction, premature appearance of aging-related diseases, and immune deficiency.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-P990982
    Denrakibart 2922866-66-6 98.24%
    HY-P990982 is an CCL17-targeting IgG2κ type human antibody, the recommed isotype control is Human IgG2 kappa, Isotype Control (HY-P99002).
    Denrakibart
  • HY-P990983
    Drotokibart 2925270-26-2
    HY-P990983 is an IL4RA-targeting IgG4κ type humanized antibody, the recommed isotype control is Human IgG4 (S228P) kappa, Isotype Control (HY-P99003).
    Drotokibart
  • HY-P990984
    Eclutatug 2922054-25-7 99.84%
    HY-P990984 is an CLDN1-targeting IgG1κ type humanized antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Eclutatug
  • HY-P990989
    Efmedaglutide alfa 2919801-97-9 98%
    HY-P990989 is an GLP-1 receptor-targeting Fusion Protein.
    Efmedaglutide alfa
  • HY-P991007
    Lotivibart 2851892-98-1 99%
    HY-P991007 is an gp120 envelope glycoprotein-targeting IgG1κ type human antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Lotivibart
  • HY-P991008
    Lunlekitug 2640257-30-1 99.9%
    HY-P991008 is an IL1A-targeting IgG1κ type human antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Lunlekitug
  • HY-P991009
    Mavrostobart 2928515-12-0 98.50%
    HY-P991009 is an NT5E-targeting IgG4κ type human antibody, the recommed isotype control is Human IgG4 (S228P) kappa, Isotype Control (HY-P99003).
    Mavrostobart
  • HY-P991012
    Nuvustotug 2916519-49-6
    HY-P991012 is an TNFRSF4-targeting IgG1κ type human antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Nuvustotug
  • HY-P991013
    Omectatug 2867393-44-8 99.07%
    HY-P991013 is an CLDN18-targeting IgG1κ type humanized antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Omectatug
  • HY-P991018
    Posnafusp alfa 2797073-53-9 98%
    HY-P991018 is an hTfR-targeting Fusion Protein.
    Posnafusp alfa
  • HY-P991019
    Recibokibart 2744274-17-5 99%
    HY-P991019 is an IL1RL2-targeting IgG1κ type humanized antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Recibokibart
  • HY-P991020
    Remzistotug 2920425-39-2
    HY-P991020 is an PVRIG-targeting IgG1κ type human antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Remzistotug
  • HY-P991024
    Solabafusp alfa 2918752-58-4 98%
    HY-P991024 is an CD274/TNFRSF9-targeting IgG4κ type humanized antibody, the recommed isotype control is Human IgG4 (S228P) kappa, Isotype Control (HY-P99003).
    Solabafusp alfa
  • HY-P991025
    Solnerstotug 2927399-38-8 99.9%
    HY-P991025 is an VSIR-targeting IgG1κ type human antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Solnerstotug
  • HY-P991030
    Tabirafusp alfa 2839527-15-8 98.08%
    HY-P991030 is an IL-6-targeting Fusion Protein.
    Tabirafusp alfa
  • HY-P991031
    Telikibart 2618667-96-0
    HY-P991031 is an IL4R-targeting IgG1κ type human antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Telikibart
  • HY-P991035
    Turenkibart 2761187-73-7 99.12%
    HY-P991035 is an IL17A-targeting IgG1κ type human antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Turenkibart
  • HY-P991037
    Verenafusp alfa 2699034-69-8 98%
    HY-P991037 is an INSR-targeting chimeric antibody.
    Verenafusp alfa
  • HY-12532S
    Astemizole-d3 1189961-39-4
    Astemizole-d3 is the deuterium labeled Astemizole. Astemizole (R 43512), a second-generation antihistamine drug to diminish allergic symptoms with a long duration of action, is a histamine H1-receptor antagonist, with an IC50 of 4 nM. Astemizole also shows potent hERG K+ channel blocking activity with an IC50 of 0.9 nM. Astemizole has antipruritic effects.
    Astemizole-d3
  • HY-66008S
    N-Acetyl mesalazine-d3 93968-79-7 98.0%
    N-Acetyl mesalazine-d3 (N-Acetyl-5-aminosalicylic acid-d3) is the deuterium labeled N-Acetyl mesalazine (HY-66008). N-Acetyl mesalazine (N-Acetyl-5-aminosalicylic acid) is the primary intestinal metabolite of 5-Aminosalicylic Acid (HY-15027) and serves as a biomarker for evaluating the efficacy of 5-Aminosalicylic Acid (HY-15027). N-Acetyl mesalazine can scavenge free radicals, reduce DNA base hydroxylation, and ameliorate mucosal inflammation. N-Acetyl mesalazine can be used in the study of diseases such as colitis and colon cancer.
    N-Acetyl mesalazine-d3
Cat. No. Product Name / Synonyms Application Reactivity